Search
  • Search

    Methylation tests 2

    HUS-yhtymä

    Methylation tests 2

    1. Competition notice published

      11. nov. 2025 kl. 08:0411. november 2025 kl. 08:04

    2. Supplier selection

      4. feb. kl. 00:004. februar 2026 kl. 00:00

    3. Contract signed

      24. feb. kl. 00:0024. februar 2026 kl. 00:00

    4. Result notice published

      26. mars kl. 11:1426. mars 2026 kl. 11:14

    Brief

    Finland: Tenders/HUS-yhtymä/Methylation tests 2

    Awarded

    The competition has ended and a winner has been selected.

    Deadline
    25. marsExpired
    Award
    Quality 20%
    Procedure
    OpenSingle stage
    Agreement
    Buying goods
    Estimated value
    €60Kover 3 years

    Brief

    HUS-yhtymä has entered into an agreement with EntroGen for the delivery of MLH1 promotor methylation tests in Finland. The agreement has a duration of 3 years, with an estimated total value of 80 000 EUR for 48 months. The selection was based on the best price-quality ratio, with price weighted at 80% and quality at 20%. One bid was received for this procurement.

    Medisinsk og laboratorieutstyr

    Result

    • EntroGen
      Winner
    • Number of bids
      1
    • Contract value
      €60,000

    Custom Assessment Criteria

    • Get answers to your bid/no-bid criteria

      Set them up once and Cobrief answers them in every tender

    Will you bid?

    The agent sets up the bid and writes the first draft. Free for 14 days.

    Award Criteria

    • Description

      Price is weighted at 80 %.

      Source

      No source found in the documents. Check the weight against the tender documents.

    • Description

      Quality is weighted at 20 %.

      Source

      No source found in the documents. Check the weight against the tender documents.

    Previous winners

    • Who are you up against?

      The suppliers who have won similar contracts at HUS-yhtymä

    From the notice

    • The HUS Group requested tenders for MLH1 methylation tests. The procurement includes the following group: - Product group 1: MLH1 promotor methylation tests The procurement was not divided into parts. The product is described in more detail in invitation to tender and in Appendix 2 (Price and product form). In the sub-area/product group 1 the most economically advantageous tender shall be selected. The criterion for determining the most economically advantageous tender shall be the best price-quality ratio. Price is weighted at 80 % and quality is weighted at 20 %. The comparison criteria for sub-area/product group 1, how to perform the comparison, and the related calculation formulas are described in more detail in the "General criteria of the group" section. The goal of this competitive procurement was to get products that are safe to use. The goal was also to have good product delivery reliability and to have products available when they are needed. The Agreement is in force for a fixed period of 3 years, and thereafter until terminated. The total estimated value of the procurement (VAT 0%) is approximately EUR 80 000 for 48 months. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.Main features of the procedurePROCUREMENT PROCEDURE This procurement is so called "national procurement". It is estimated to be under the EU threshold value defined in the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). According to 100 § of Public Procurement Act the contracting entity shall outline the procurement procedure that it applies in the call for tenders documents. Procurement procedure is described as follows: PROCESSING OF TENDERS The procedure shall include the following phases: Contracting entity 1. Opens the tenders 2. Verifies the suitability of the tenderer 3. Checks that the tenders conform to the invitation to tender 4. Compares the tenders [POSSIBLE TRIAL USE] 5. Requests and checks certificates and reports on the suitability of the winning tenderer(s) 6. Makes a procurement decision and communicates it to all the tenderers 7. Concludes an agreement with the selected tenderer(s) In steps 2.-5. a contracting entity may (i) select as the winner of the competitive tendering the tenderer best evaluated on the basis of the comparative criteria; or (ii) move to a negotiated procedure. A negotiated procedure may be used if: (i) the competitive tendering procedure did not result in tenders that match the call for tenders; (ii) no tenders could be accepted due to a too high price or other reason; or (iii) HUS deems it necessary to negotiate the details of the tenders All tenderers who have submitted a tender within the time limit and meet the suitability requirements shall be invited to negotiate. The aim of the negotiations is to update the original call for tenders so that the tenderers selected for the negotiations can submit new tenders on the basis of it. Negotiations are conducted on an equal basis with all invited tenderers for the time specified by the HUS. After the negotiations, HUS will deliver an updated call for tenders to all bidders involved in the negotiations, on the basis of which the tenderers will submit new tenders. New tenders are compared according to the criteria described in the new call for tenders and the winning tenderer is selected on the basis of this comparison. Once the winner of the tendering process has been selected, HUS will make the procurement decision and communicate the decision to all tenderers. LANGUAGE OF THE COMPETITIVE TENDERING PROCEDURE The procurement documents are available in English. If a tenderer needs the documents in another language, the tenderer shall be responsible for translation and liable for the associated costs. Tenders must be prepared in English. PARALLEL TENDERS Parallel tenders are allowed.

    • Contact

      Kilpailutustiimikilpailutus.tiimi@hus.fi
    • Type
      Result
    • Main code
      Medical equipments, pharmaceuticals and personal care products
      33000000
    • 33696000Reagents and contrast media33696500Laboratory reagents

    Similar active competitions

    • HUS-yhtymä

      Laboratorie- og analyseutstyr

      MLPA-Based CNV Testing for BRCA1/BRCA2

      HUS Group, the joint authority for Helsinki and Uusimaa, needs an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licenses, and other components required for routine use and generation of reportable patient results. The contract period is 2 years, after which it continues indefinitely until terminated. The estimated annual consumption is approximately 1600 reportable patient samples, to be delivered to the HUSLAB Laboratory of Genetics in Helsinki-Uusimaa, Finland. The award criterion is the lowest total comparison price.

      Competition
      9. nov. 2026(11 days)

    • HUS-yhtymä

      Helse- og sosial tjenesteyting

      HUS Subcontracting genetic diagnostic tests

      HUS Group needs genetic diagnostic test services to support clinical patient work and individual patient treatment decisions. These services are for various clinics within the HUS Joint Municipal Authority for Specialised Health Care, and also for ISLAB (Eastern Finland Laboratory Centre, Joint Authority Enterprise). The services are procured through a dynamic purchasing system. Suppliers must have a yearly turnover of at least EUR 500,000, a risk category of RL1-RL3, professional experience with similar genetic diagnostic test services for reference customers during the last three years, and the laboratory must have accreditation status secured for at least two years. Additionally, candidates must have experience in supplying at least 5000 genetic studies yearly for university-level or similar hospitals within the EU/EEA area. Award criteria for specific competitions will be based on overall financial affordability, which may include price and/or quality.

      Dynamic purchasing system
      9. mai 2030(100+ days)